Navigation Links
Accuray Announces Results for Second Quarter Fiscal 2013
Date:2/6/2013

changes to the value of assets and liabilities from the amounts reflected by TomoTherapy prior to the acquisition and the creation of incremental assets and liabilities including intangible assets for developed technology and backlog, and unfavorable lease obligations. These changes have impacted revenues and expenses recorded in Accuray's consolidated statements of operations since the close of the acquisition. In addition, Accuray has incurred significant expenses as a result of the acquisition, some of which are one-time charges while others were incurred over fiscal 2012 and 2013 for the integration of TomoTherapy.

To reflect the ongoing core results of operations of the Company, including adjusting for the impact of the acquisition of TomoTherapy, the Company has presented its operating results on an adjusted non-GAAP basis as well as in accordance with GAAP for the three and six months ended December 31, 2012 and 2011. We use the following measures shown in the following tables, which are not calculated in accordance with GAAP. All significant adjustments to reconcile to GAAP primarily relate to the acquisition of TomoTherapy except the adjustment to Other income (expense). The Company believes that the presentation of non-GAAP financial measures provides useful supplementary information to and facilitates additional analysis by investors. The Company uses these non-GAAP financial measures in connection with its own budgeting and financial planning, as well as evaluating management performance for compensation purposes. These non-GAAP financial measures are in addition to, not a substitute for, nor superior to, measures of financial performance prepared in conformity with GAAP.

 

 

 RevenueThree months ended December 31,Three Months Ended December 31,Six Months Ended December 31,Six Months Ended December 31,201220122012201120112011201220122012201120112011GAAPAdjustmentsNon-GAAPGAAPAdjustmentsNon-GAAPGAAPAdjustmentsNo
'/>"/>

SOURCE Accuray Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Accuray Announces Proposed Offering Of $75 Million Of Convertible Senior Notes
2. Accuray Incorporated to Report Financial Results for Second Quarter Fiscal 2013
3. Accuray Incorporated to Speak at 23rd Annual Oppenheimer Healthcare Conference
4. Accuray Incorporated to Speak at 24th Annual Piper Jaffray Healthcare Conference
5. Accuray Incorporated to Speak at Lazard Capital Markets Healthcare Conference
6. 90 Presentations at Leading Radiation Oncology Meeting Demonstrate the Breadth and Depth of Clinical Evidence for Accuray Technologies
7. Accuray Announces Results for Fourth Quarter and Fiscal Year 2012
8. Accuray Incorporateds CEO to Speak at Morgan Stanley Global Healthcare Conference
9. Accuray to Acquire Morphormics, Inc.
10. Accuray and Erasmus Medical Center Sign Master Research and Collaboration Agreement
11. One Year After TomoTherapy Acquisition, Accuray on Track to Meet or Exceed Integration Success Metrics And Expecting Near-term Return to Profitability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... 2014 Hovione announced today it ... with the U.S. Food and Drug Administration (FDA). This ... improved drug delivery options for established drugs. ... formulation using a new patented crystalline base form of ... prescribed oral antibiotics for acne. Currently, there are no ...
(Date:11/27/2014)... TOKYO , Nov. 27, 2014 ... Available to Academic Research - JIN Co., Ltd. ... at a market price of 500,000 yen or $5,000 (without ... analysis software). The "ACADEMIC PACK" is a dedicated solution of ... directly capture and analyze deep data* generated by electrooculography and ...
(Date:11/26/2014)... -- Thoratec Corporation (NASDAQ: THOR ), a world ... support and restore failing hearts, said today it will ... On Tuesday, December 2, the company will participate in ... D. Keith Grossman , President and Chief Executive ... at 11:30 a.m., Eastern Standard Time (8:30 a.m., Pacific ...
Breaking Medicine Technology:Hovione Files its First Investigational New Drug Application With the FDA 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Thoratec Announces Presentations At Investor Conferences For December 2014 2
... (ERT), (Nasdaq: ERT ) a global ... to biopharmaceutical and healthcare organizations and the market leader ... in drug development, announced today results for the ... noted, all comparative numbers refer to changes from ...
... MOUNTAIN VIEW, Calif., Aug. 1, 2011 VIVUS, Inc. ... development and commercialization of novel therapeutic products, today reported its financial ... 2011. Second Quarter ResultsFor the second quarter ... million, or $0.20 per share, as compared to a net loss ...
Cached Medicine Technology:ERT Reports Second Quarter 2011 Operating Results 2ERT Reports Second Quarter 2011 Operating Results 3ERT Reports Second Quarter 2011 Operating Results 4ERT Reports Second Quarter 2011 Operating Results 5ERT Reports Second Quarter 2011 Operating Results 6ERT Reports Second Quarter 2011 Operating Results 7ERT Reports Second Quarter 2011 Operating Results 8ERT Reports Second Quarter 2011 Operating Results 9ERT Reports Second Quarter 2011 Operating Results 10ERT Reports Second Quarter 2011 Operating Results 11ERT Reports Second Quarter 2011 Operating Results 12ERT Reports Second Quarter 2011 Operating Results 13VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 2VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 3VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 4VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 5VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 6VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 7
(Date:11/27/2014)... 2014 Absolute PhysioCare & Sports ... that its personalized treatment plans, highly skilled and ... victims of sports injuries reach pre-injury state. Whether ... pain syndrome, Absolute Physio has the right treatment ... ACL tears, meniscal injuries, groin strain and sports ...
(Date:11/27/2014)... According to a recent report by iData Research ... the surgical robotics market may find significant ... field dominated by Intuitive. These companies are expected to ... by 2020. , “The MIS robotic device market ... President of iData. “System sales for the da Vinci ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Luciana Lagana ... to be part of Omadox, a feature film that received ... an award for best ensemble cast. It is also an ... a great start to a successful cinematic career for James ... white movies. If you enjoy experimental mystery, filmed in glorious ...
(Date:11/27/2014)... 27, 2014 Cambrionix Ltd today announced that ... 50, a ranking of the 50 fastest-growing technology companies in ... over the last five years. Cambrionix Ltd grew 2989 ... first in the region of Cambridgeshire and East and first ... Says:, “This award is recognition of the hard work put ...
(Date:11/27/2014)... November 27, 2014 In a ... allot to sleep has lessened, and due to ... the quality of sleep has eroded. According to ... on the job (Reference: http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ). This ... index by an incalculable amount, leading not only ...
Breaking Medicine News(10 mins):Health News:Coquitlam Physiotherapy Clinic Now Helps Clients Reach Pre-Injury State 2Health News:U.S. Robotic Surgery Market Set to Diversify and Grow: Intuitive Surgical’s ‘da Vinci’ Robot Revenues to Increasingly Rely On Procedures and Services 2Health News:Luciana Lagana and Gregory Graham Join the Award-Winning Cast of the Black-and-White Experimental Mystery Feature Film Omadox. 2Health News:Luciana Lagana and Gregory Graham Join the Award-Winning Cast of the Black-and-White Experimental Mystery Feature Film Omadox. 3Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 2Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 3Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 4Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2
... Alan Mozes HealthDay Reporter , SATURDAY, Dec. 4 ... be an effective, convenient and safer treatment for patients coping ... According to the research, published online Dec. 4 in ... could offer a new option for these potentially life-threatening ...
... 3 (HealthDay News) -- Use of androgen suppression therapy ... receiving lower Medicare payments for the treatment, but use ... stayed steady, a new study shows. The findings, ... the National Cancer Institute , suggest the payment cuts ...
... standards for outcome reporting in breast reconstruction are needed, ... The Journal of the National Cancer Institute. ... to 40% of women with breast cancer undergo a ... decision-making is information from health professionals. However, that information ...
... FRIDAY, Dec. 3 (HealthDay News) -- New research explains why immune ... drug-resistant HIV. In those cases, the virus has mutations that ... to kill immune cells, explained the researchers at the Mayo Clinic ... that not all HIV is equally bad for the immune system, ...
... a new standard treatment for Breast Cancer at early ... 0 funded by Spanish Breast Cancer Research Group (GEICAM) ... thousand patients and 50 hospitals participated in the study, ... The New England Journal of Medicine. Results indicate that ...
... 3 (HealthDay News) -- A protein that regulates prostate stem ... of healthy cells into prostate cancer cells has been identified ... protein, could prove important in efforts to find ways to ... from the University of California, Los Angeles. Previous research ...
Cached Medicine News:Health News:New Blood Thinner May Help Fight Dangerous Leg Clots 2Health News:New Blood Thinner May Help Fight Dangerous Leg Clots 3Health News:Medicare Cuts May Have Spurred Drop in Prostate Cancer Treatment 2Health News:Improvement needed for mastectomy outcome reporting 2Health News:Spanish Oncology to establish a new standard treatment on breast cancer at early stages 2Health News:Spanish Oncology to establish a new standard treatment on breast cancer at early stages 3
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
... special order products are offered as 1-piece ... lengths. The modular instruments may be customized ... such as ratchets, insulation and flush ports. ... stock. Customer specifications may affect delivery times. ...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
... Many special order products are offered as ... long lengths. The modular instruments may be ... options such as ratchets, insulation and flush ... Mediflex stock. Customer specifications may affect delivery ...
Medicine Products: